2019 Endowment Fund Grants: successful grant recipients
17 September 2019
Twenty-two new ground-breaking Peter Mac cancer research projects will be established thanks to the generosity of donors to the Foundation’s Perpetual Endowment Fund. In total, $1.1m in seed funding was awarded through the Foundation's 2019 Endowment Fund Grants program to help kick-start some of Peter Mac's most exciting new cancer research initiatives.
Our most grateful thanks go to the generous individuals who have enabled these annual Grants by donating to the Foundation's Endowment Fund.
Recipients of this year's Grants are:
Alexander, Marliese
Australian registry for ROS1 rearranged non-small cell lung cancer - a framework for prospective collection of clinical data and consent to access biospecimens.
Division: Cancer Medicine
Atkin, Nicola
An open-label, single-arm feasibility study of oral lorazepam for symptoms of anxiety in patients with advanced cancer.
Chief Medical Officer
Brennan, Amelia
Overcoming tumour cell resistance to natural immunity and immunotherapy.
Division: Research
Burdett, Nikki
Emquest-Identifying factors which predict for health-related quality of life deficits and increased symptom burden in women who have been treated for endometrial cancer.
Division: Medical Oncology
Christie, Liz
Understanding spatial patterning of resistance in ovarian cancer.
Division: Cancer Research
Clemons, Nicholas
Multiplexed single-cell CRISPR activation and knockout tumourigenesis screen to establish functional genetic drivers of oesophageal adenocarcinoma.
Division: Cancer Research
Haskali, Mohammad
Development of Ga-68/Lu-177 labelled Carfilzomib for the diagnosis and therapy of Multiple Myeloma.
Division: Radiation Oncology
Hoskins, Cass
Young people's experiences of managing significantly increased risk of gastric cancer due to a CDH1 mutation.
Division: Parkville Familial Cancer Centre
Joyce, Trish
Precision preparation: Working with haematology patients and family carers to safely deliver outpatient complex cancer therapies.
Division: Nursing
Lai, Junyun
Using new generation CRISPR/Cas9-mediated genomic engineering to enhance CAR T-cell efficacy in solid cancers.
Division: Cancer Research
Lewin, Jeremy
RNAseq-based assay for diagnosis and clinical management of sarcoma.
Division: ONTrac at Peter Mac Victorian Adolescent & Young Adult Cancer Service
Liddicoat, Brian
Understanding the clonal evolution and maintenance of CAR T-cell persistence.
Division: Cancer Epigenetics
Lonski, Peta
3-dimensional modelling of radiation doses to the lungs of patients undergoing total body irradiation treatment for haematological malignancies.
Division: Radiation Oncology
Lupat, Richard
Powering Personalised Medicine through FPGA-based Ultra-Rapid Secondary Analysis of NGS Data.
Division: Cancer Research
McDonald, Geraldine
Supporting staff to deliver better EoL care.
Division: Chief Medical Officer
Pereira, Lloyd
A tumouroid based preclinical model for Adenoid Cystic Carcinoma of the Salivary Gland.
Division: Cancer Research
Ryland, Georgina
Identifying Ph-like B-acute lymphoblastic leukaemia - a poor risk subtype with the potential for targeted therapy.
Division: Centre for Clinical Cancer Genomics
Smith, Cassandra
Improving consumer engagement in cancer research: Identifying and minimising the barriers for consumers to partner with researchers.
Division: Medical
Vassiliadis, Dane
Single-cell analysis of non-genomic cancer cell adaptation to therapeutic intervention.
Division: Cancer Research
Vervoort, Stephin
Feature-seq: Simultaneous single cell RNA-sequencing and surface protein expression profiling on pooled mouse or patient tumour filtrating T-cell samples.
Division: Research (Translational Haematology)
Voskoboinik, Ilia
Understanding cancer cell resistance to cytotoxic lymphocytes and immunotherapy.
Division: Research
Yong, Michelle
Biomarker predictors for respiratory viral and fungal infections in malignant haematology and haematopoietic stem cell transplant recipients.
Division: Chief Medical Officer
